Century Therapeutics, Inc. - IPSC

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 17, 2026 SCHEDULE 13G/A Point72 Asset Management, L.P. 6.8% 5,961,563 View
Feb 17, 2026 SCHEDULE 13G/A Point72 Capital Advisors, Inc. 6.8% 5,961,563 View
Feb 17, 2026 SCHEDULE 13G/A Steven A. Cohen 6.8% 5,961,563 View
Jan 16, 2026 SCHEDULE 13G RA Capital Management, L.P. 9.9% 17,944,649 View
Jan 16, 2026 SCHEDULE 13G Peter Kolchinsky 9.9% 17,944,649 View
Jan 16, 2026 SCHEDULE 13G Rajeev Shah 9.9% 17,944,649 View
Jan 16, 2026 SCHEDULE 13G RA Capital Healthcare Fund, L.P. 9.9% 17,944,649 View
Jan 16, 2026 SCHEDULE 13G Venrock Healthcare Capital Partners III, L.P. 7.1% 13,043,478 View
Jan 16, 2026 SCHEDULE 13G VHCP Co-Investment Holdings III, LLC 7.1% 13,043,478 View
Jan 16, 2026 SCHEDULE 13G Venrock Healthcare Capital Partners EG, L.P. 7.1% 13,043,478 View
Jan 16, 2026 SCHEDULE 13G VHCP Management III, LLC 7.1% 13,043,478 View
Jan 16, 2026 SCHEDULE 13G VHCP Management EG, LLC 7.1% 13,043,478 View
Jan 16, 2026 SCHEDULE 13G Nimish Shah 7.1% 13,043,478 View
Jan 16, 2026 SCHEDULE 13G Bong Y. Koh 7.1% 13,043,478 View
Jan 16, 2026 SCHEDULE 13G Commodore Capital LP 7.1% 13,043,478 View
Jan 16, 2026 SCHEDULE 13G Commodore Capital Master LP 7.1% 13,043,478 View
Jan 16, 2026 SCHEDULE 13G Robert Egen Atkinson 7.1% 13,043,478 View
Jan 16, 2026 SCHEDULE 13G Michael Kramarz 7.1% 13,043,478 View
Jan 15, 2026 SCHEDULE 13G TCG Crossover GP II, LLC 4.9% 8,877,215 View
Jan 15, 2026 SCHEDULE 13G TCG Crossover Fund II, L.P. 4.9% 8,877,215 View
Jan 15, 2026 SCHEDULE 13G TCG Crossover GP III, LLC 4.9% 8,877,215 View
Jan 15, 2026 SCHEDULE 13G TCG Crossover Fund III, L.P. 4.9% 8,877,215 View
Jan 15, 2026 SCHEDULE 13G Chen Yu 9.9% 17,754,430 View
Jan 15, 2026 SCHEDULE 13G Deep Track Capital, LP 7.34% 13,486,400 View
Jan 15, 2026 SCHEDULE 13G Deep Track Biotechnology Master Fund, Ltd. 5.78% 10,609,008 View
Jan 15, 2026 SCHEDULE 13G David Kroin 7.34% 13,486,400 View
Jan 15, 2026 SCHEDULE 13G Deep Track Special Opportunities Fund, LP. 1.57% 2,877,392 View
Jan 05, 2026 SCHEDULE 13G Point72 Asset Management, L.P. 5.4% 4,725,639 View
Jan 05, 2026 SCHEDULE 13G Point72 Capital Advisors, Inc. 5.4% 4,725,639 View
Jan 05, 2026 SCHEDULE 13G Steven A. Cohen 5.4% 4,725,639 View
Nov 14, 2025 SCHEDULE 13G/A Bain Capital Life Sciences Opportunities III, LP 4.1% 3,538,609 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.